NKL
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Nickelx Limited
π¦πΊ ASX
βοΈ MINING
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-25.35%
Annual Growth
3 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
NickelX Ltd. provides exploration services. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-05-07. The Companyβs primary focus is the Elliot Lake Uranium Project and the highly prospective Dalwallinu nickel-copper-PGE project. Its 100%-owned Elliot Lake Uranium Project is located in south-central Ontario and covers about 30 multi-cell mining claims spanning 129 square kilometers and is located along a strike from the Elliot Lake Uranium district. The Dalwallinu Nickel Project (E70/5398) covers about 86 square kilometers of the underexplored Barra Barra Greenstone belt in the emerging West Yilgarn Nickel-Copper-PGE Province. Its Biranup project is an early-stage nickel-copper-cobalt and gold project located in the north-eastern Albany-Fraser belt, approximately 350 kilometers (km) north-east of Kalgoorlie. Its Cosmos South Nickel Project is located about 10 km south of the Cosmos Nickel operations.
π Performance
Price History
-85.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
0%
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.03
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in NKL
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in NKL
N/A
NKL investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in NKL also invest in...
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
π Performance (5Yr p.a)
23.84%
π Share price
$43.23 AUD
π HIGH PRICE GROWTH
π€ TECHNOLOGY
πΊπΈ UNITED STATES
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The firm is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).
π Performance (5Yr p.a)
222.06%
π Share price
$18.76 AUD
𧬠BIOTECHNOLOGY
MVW.AX was created on 2014-03-04 by VanEck. The fund's investment portfolio concentrates primarily on large cap equity. MVW.AX invests in a diversified portfolio of ASX-listed securities with the aim of providing investment returns before fees and other costs that track the performance of the MVIS Australia Equal Weight Index
π Performance (5Yr p.a)
3.67%
π Share price
$36.92 AUD
π¦πΊ AUSTRALIA
πΈ FINANCIALS
ποΈ CONSUMER
π REAL ESTATE
QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
π Performance (5Yr p.a)
18.36%
π Share price
$54.35 AUD
π COMMUNICATIONS
πΊπΈ UNITED STATES
π€ TECHNOLOGY
π HIGH PRICE GROWTH
π©Ί HEALTH CARE
Woolworths Group Ltd. engages in the operation of general merchandise consumer stores and supermarkets in Australia, New Zealand and India. The company is headquartered in Sydney, New South Wales and currently employs 200,364 full-time employees. The firm's segments include Australian Food, Australian B2B, New Zealand Food, BIG W and Other. The Australian Food segment is engaged in procurement of food, drinks and related products for resale and provision of services (including eCommerce) to retail and business customers in Australia. The Australian B2B segment includes procurement and distribution of food and related products for resale to other businesses and provision of supply chain services to business customers in Australia. The New Zealand Food segment includes procurement of food, drinks and related products for resale and provision of services (including eCommerce) to retail and wholesale customers in New Zealand. The BIG W segment includes procurement of discount general merchandise products for resale (including via eCommerce) to retail customers in Australia. The Other segment comprises Quantium and MyDeal as well as various support functions.
π Performance (5Yr p.a)
1.32%
π Share price
$35.24 AUD
ποΈ CONSUMER